0001209191-21-042031.txt : 20210621
0001209191-21-042031.hdr.sgml : 20210621
20210621163626
ACCESSION NUMBER: 0001209191-21-042031
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210617
FILED AS OF DATE: 20210621
DATE AS OF CHANGE: 20210621
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCGRAW BENJAMIN F III
CENTRAL INDEX KEY: 0001216994
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36152
FILM NUMBER: 211031210
MAIL ADDRESS:
STREET 1: 863A MITTEN ROAD
CITY: BURLINGAME
STATE: CA
ZIP: 94010
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AERIE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001337553
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 203109565
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4301 EMPEROR BOULEVARD
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
BUSINESS PHONE: (919) 237-5300
MAIL ADDRESS:
STREET 1: 4301 EMPEROR BOULEVARD
STREET 2: SUITE 400
CITY: DURHAM
STATE: NC
ZIP: 27703
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-06-17
0
0001337553
AERIE PHARMACEUTICALS INC
AERI
0001216994
MCGRAW BENJAMIN F III
C/O AERIE PHARMACEUTICALS, INC.
4301 EMPEROR BLVD., SUITE 400
DURHAM
NC
27703
1
0
0
0
Common Stock
2021-06-17
4
A
0
1750
0.00
A
11550
D
Stock Option (right to buy)
16.21
2021-06-17
4
A
0
7800
0.00
A
2031-06-17
Common Stock
7800
7800
D
Subject to the reporting person's continued service on the board of directors of the issuer through the vesting date, these shares of Common Stock are scheduled to vest on June 17, 2022.
Subject to the reporting person's continued service on the board of directors of the issuer through the applicable vesting date, this option is scheduled to vest ratably on each of the first 12 monthly anniversaries of June 17, 2021.
/s/ John LaRocca, Attorney-in-Fact for Benjamin F. McGraw, III
2021-06-21